top of page
it's where dermatology lives
Most patients with advanced melanoma remain disease-free four years after pre-surgical immunotherapy
Elizabeth Burton, PhD. Photo courtesy The University of Texas MD Anderson Cancer Center In a significant advance for the management of...
Allan Ryan
Jul 142 min read
SARS-COV-2 mRNA vaccines improve clinical responses to immune checkpoint inhibition
In a new study, researchers have identified benefits of SARS-COV-2 mRNA vaccines for cancer patients undergoing immunotherapy. The...
Allan Ryan
Nov 18, 20242 min read
Modulating the gut microbiome may improve response to ICB therapy
Deciphering and modifying the composition of various gut bacteria may improve immune checkpoint blockade (ICB) treatment responses in...
Allan Ryan
Apr 8, 20242 min read
Combination LAG-3/PD-1 inhibition superior to PD-1 inhibition monotherapy for metastatic melanoma
Findings from a new study suggest that inhibiting both the LAG-3 and PD-1 immune checkpoints in patients with previously untreated...
John Evans
Jan 7, 20222 min read
Featured Posts
bottom of page